Equity Overview
Price & Market Data
Price: $1.24
Daily Change: $0.00 / 0.00%
Range: $1.20 - $1.24
Market Cap: $228,027,312
Volume: 2,747
Performance Metrics
1 Week: -13.29%
1 Month: 12.73%
3 Months: 5.98%
6 Months: 24.30%
1 Year: 42.17%
YTD: 20.39%
Company Details
Employees: 18
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. The company was founded in 2020 and is headquartered in Warren, New Jersey.